SCHEMBL17355694

SCHEMBL17355694

Cc1cc(OS(=O)(=O)c2ccc(F)c(F)c2)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
PTGS2 P35354 4/20 0.44
SOS1 Q07889 1/20 0.44
PTGS1 P23219 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 1/20 0.41
APEX1 P27695 1/20 0.41
TSHR P16473 2/20 0.40
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
ALPL P05186 1/20 0.39
ALPI P09923 1/20 0.39
TNF P01375 1/20 0.38
MAOB P27338 1/20 0.38
SLC22A12 Q96S37 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355692 0.87 AKR1C3 (0.47) KMT2ASOS1SMN1; SMN2TDP1L3MBTL1
SCHEMBL17355689 0.87 KMT2A (0.55) KMT2ASMN1; SMN2TDP1L3MBTL1LMNA
SCHEMBL17355680 0.84 TDP1 (0.56) KMT2ASMN1; SMN2TDP1L3MBTL1LMNA
SCHEMBL17355687 0.82 ENPP3 (0.48) KMT2APTGS2PTGS1SMN1; SMN2TDP1
SCHEMBL10656325 0.79 SOS1 (0.46) KMT2ASOS1SMN1; SMN2TDP1L3MBTL1
SCHEMBL17355696 0.79 CA1 (0.46) KMT2APTGS2PTGS1SMN1; SMN2LMNA
SCHEMBL17356466 0.78 SOS1 (0.42) KMT2ASOS1SMN1; SMN2TDP1L3MBTL1
SCHEMBL30626033 0.78 TDP1 (0.51) KMT2ASOS1SMN1; SMN2TDP1L3MBTL1
SCHEMBL17355677 0.78 PTGS2 (0.39) KMT2APTGS2SOS1PTGS1SMN1; SMN2
SCHEMBL7247499 0.78 ALDH1A1 (0.49) KMT2APTGS2PTGS1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 KMT2A 2355/4885PTGS2 3718/4885SOS1 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.